Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Fox

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 28, 2022
Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognitionPratishtha Chatterjee, Lisa Vermunt, Brian A Gordon, et al.
JAMA Neurology|November 1, 2024
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group RecommendationBruno Dubois, Nicolas Villain, Lon Schneider, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 4, 2011
No evidence that extended tracts of homozygosity are associated with Alzheimer's diseaseRebecca Sims, Sarah Dwyer, Denise Harold, et al.
Molecular Psychiatry|March 23, 2019
The BDNF<sub>Val66Met</sub> SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's diseaseNicolai Franzmeier, Jinyi Ren, Alexander Damm, et al.
European Journal of Epidemiology|April 25, 2020
The Dementias Platform UK (DPUK) Data PortalSarah Bauermeister, Christopher Orton, Simon Thompson, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialRandall J Bateman, Yan Li, Eric M McDade, et al.
Plos One|November 19, 2010
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's diseaseLesley Jones, Peter A Holmans, Marian L Hamshere, et al.
Acta Neuropathologica|January 21, 2014
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansionsMichael D Gallagher, Eunran Suh, Murray Grossman, et al.
Nature Genetics|September 8, 2009
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseDenise Harold, Richard Abraham, Paul Hollingworth, et al.
Journal of Alzheimer'S Disease : JAD|October 27, 2011
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's diseaseAmy Gerrish, Giancarlo Russo, Alexander Richards, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 28, 2022
Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognitionPratishtha Chatterjee, Lisa Vermunt, Brian A Gordon, et al.
JAMA Neurology|November 1, 2024
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group RecommendationBruno Dubois, Nicolas Villain, Lon Schneider, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 4, 2011
No evidence that extended tracts of homozygosity are associated with Alzheimer's diseaseRebecca Sims, Sarah Dwyer, Denise Harold, et al.
Molecular Psychiatry|March 23, 2019
The BDNF<sub>Val66Met</sub> SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's diseaseNicolai Franzmeier, Jinyi Ren, Alexander Damm, et al.
European Journal of Epidemiology|April 25, 2020
The Dementias Platform UK (DPUK) Data PortalSarah Bauermeister, Christopher Orton, Simon Thompson, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialRandall J Bateman, Yan Li, Eric M McDade, et al.
Plos One|November 19, 2010
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's diseaseLesley Jones, Peter A Holmans, Marian L Hamshere, et al.
Acta Neuropathologica|January 21, 2014
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansionsMichael D Gallagher, Eunran Suh, Murray Grossman, et al.
Nature Genetics|September 8, 2009
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseDenise Harold, Richard Abraham, Paul Hollingworth, et al.
Journal of Alzheimer'S Disease : JAD|October 27, 2011
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's diseaseAmy Gerrish, Giancarlo Russo, Alexander Richards, et al.
Pageof 6